Targeting the Microbiota Reverses C‐Section‐Induced Effects on Intestinal Permeability, Microbiota Composition, and Amygdala Gene Expression in the Mouse
Neurogastroenterology & Motility · 2025-12 · 37 (12)
DOI: 10.1111/nmo.70107 ↗At a glance
Journal article in Neurogastroenterology & Motility, published online on 2025-06-26. Written by Ana Paula Ventura Silva and 12 co-authors. Institution: Department of Anatomy and Neuroscience, University College Cork, Cork, Ireland. Major MEDLINE topics: Gastrointestinal Microbiome, Amygdala, Cesarean Section, Intestinal Mucosa. Cited 3 times so far (Crossref); 60 references. The full text is freely available (open access, CC BY 4.0). Funded by: Science Foundation Ireland.
Abstract (original language)
Background
The microbiome significantly influences the development of the gastrointestinal and immune systems. The delivery method, whether Caesarean section (CS) or vaginal birth (VB), plays a crucial role in shaping microbiota composition, with CS babies exhibiting differences. Early‐life nutritional interventions using probiotics or prebiotics may help restore this imbalance in CS infants. Our study aimed to assess gut permeability in CS mice compared to VB mice and explore whether prebiotics or probiotics could mitigate any deficiencies.
Methods
Using a mouse model (NIH Swiss) for CS delivery, we measured plasma levels of a 4 kDa macromolecule (FITC) at PND7, 14, 23, and 35. We evaluated ileal gene expression of tight junction proteins, profiled intestinal microbiome composition, and examined the expression of genes involved in neurotransmitter physiology in the amygdala. Additionally, we studied the impact of administering Bifidobacterium breve in drinking water and dietary administration of GOS/FOS on these outcomes. Key Results At PND7, CS‐born mice exhibited increased ileal permeability, along with reduced expression of Tjp1, Occludin, Claudin 3, and Epcam compared to VB mice. Administration of B. breve or GOS/FOS alleviated changes in Epcam expression. During the pre‐weaning period, beta diversity differed between VB and CS. Post‐weaning, β‐diversity increased following probiotic and prebiotic intervention. Additionally, CS mice showed changes in neurotransmitter gene expression in the amygdala, which were also mitigated by B. breve or GOS/FOS.
Discussion
Our findings indicate that targeted microbiota‐associated interventions can reverse deficits in intestinal permeability induced in CS mice.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Anatomy and Neuroscience, University College Cork, Cork, Ireland.
- APC Microbiome Ireland, University College Cork, Cork, Ireland.
- Danone Nutricia Research, Utrecht, the Netherlands.
- Department of Psychiatry and Neurobehavioural Science, University College Cork, Cork, Ireland.
ORCID profiles: Gerard M Moloney
Funding
- Science Foundation Ireland
Cite
APA
Silva, A. P. V., Moloney, G. M., Sequeira, A. M., Liber, M., Bastiaanssen, T., Rea, K., Fitzgerald, P., Golubeva, A., Rodriguez-Aburto, M., Renes, I. B., Knol, J., Dinan, T., & Cryan, J. F. (2025). Targeting the Microbiota Reverses C‐Section‐Induced Effects on Intestinal Permeability, Microbiota Composition, and Amygdala Gene Expression in the Mouse. Neurogastroenterology & Motility, 37(12). https://doi.org/10.1111/nmo.70107
Vancouver
Silva APV, Moloney GM, Sequeira AM, Liber M, Bastiaanssen T, Rea K, et al. Targeting the Microbiota Reverses C‐Section‐Induced Effects on Intestinal Permeability, Microbiota Composition, and Amygdala Gene Expression in the Mouse. Neurogastroenterology & Motility. 2025;37(12). doi:10.1111/nmo.70107
BibTeX
@article{Silva2025,
author = {Silva, Ana Paula Ventura and Moloney, Gerard M and Sequeira, Ana Marta and Liber, Marta and Bastiaanssen, Thomaz and Rea, Kieran and Fitzgerald, Patrick and Golubeva, Anna and Rodriguez-Aburto, Maria and Renes, Ingrid B and Knol, Jan and Dinan, Timothy and Cryan, John F},
title = {Targeting the Microbiota Reverses C‐Section‐Induced Effects on Intestinal Permeability, Microbiota Composition, and Amygdala Gene Expression in the Mouse},
journal = {Neurogastroenterology & Motility},
year = {2025},
volume = {37},
number = {12},
doi = {10.1111/nmo.70107}
}
EUVIMED